Targeted Nanotheranostics for Future Personalized Medicine: Recent Progress in Cancer Therapy

Overview

Journal Theranostics

Date 2016 Jul 5

PMID 27375785

Citations 61

Authors

Sung Duk Jo

Sook Hee Ku

You-Yeon Won

Sun Hwa Kim

Ick Chan Kwon

Affiliations

Soon will be listed here.

Abstract

Recently, many theranostic nanomaterials have been developed by integrating therapeutic and diagnostic agents in a single regimen. Real-time visualization of nano drug carrier biodistributions, drug release processes and therapeutic responses can provide critical information needed for dynamically optimizing treatment operations in a personalized manner in real time. This review highlights recent progresses in the development of multifunctional nanoparticles possessing both therapeutic and imaging functionalities for cancer therapy. The advantages of using nanoparticle platforms are discussed. Examples demonstrating various combinations of imaging and therapeutic modalities are highlighted.

Citing Articles

Nanomedicine mediated thyroid cancer diagnosis and treatment: an approach from generalized to personalized medicine.

Gulwani D, Upadhyay P, Goel R, Sarangthem V, Singh T Discov Oncol. 2024; 15(1):789.

PMID: 39692930 PMC: 11656002. DOI: 10.1007/s12672-024-01677-8.

Polymer-drug conjugates: revolutionizing nanotheranostic agents for diagnosis and therapy.

Parashar A, Saraogi G, Jain P, Kurmi B, Shrivastava V, Arora V Discov Oncol. 2024; 15(1):641.

PMID: 39527173 PMC: 11554983. DOI: 10.1007/s12672-024-01509-9.

Bacterial derivatives mediated drug delivery in cancer therapy: a new generation strategy.

Ijaz M, Hasan I, Chaudhry T, Huang R, Zhang L, Hu Z J Nanobiotechnology. 2024; 22(1):510.

PMID: 39182109 PMC: 11344338. DOI: 10.1186/s12951-024-02786-w.

Artificial intelligence for cardiovascular disease risk assessment in personalised framework: a scoping review.

Singh M, Kumar A, Khanna N, Laird J, Nicolaides A, Faa G EClinicalMedicine. 2024; 73:102660.

PMID: 38846068 PMC: 11154124. DOI: 10.1016/j.eclinm.2024.102660.

Design consideration of phthalocyanines as sensitizers for enhanced sono-photodynamic combinatorial therapy of cancer.

Nene L, Abrahamse H Acta Pharm Sin B. 2024; 14(3):1077-1097.

PMID: 38486981 PMC: 10935510. DOI: 10.1016/j.apsb.2023.11.030.

References

Riedl S, Shi Y . Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol. 2004; 5(11):897-907. DOI: 10.1038/nrm1496. View

Xie J, Lee S, Chen X . Nanoparticle-based theranostic agents. Adv Drug Deliv Rev. 2010; 62(11):1064-79. PMC: 2988080. DOI: 10.1016/j.addr.2010.07.009. View

Nam H, Kwon S, Chung H, Lee S, Kwon S, Jeon H . Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J Control Release. 2009; 135(3):259-67. DOI: 10.1016/j.jconrel.2009.01.018. View

Raymond K, Pierre V . Next generation, high relaxivity gadolinium MRI agents. Bioconjug Chem. 2005; 16(1):3-8. DOI: 10.1021/bc049817y. View

Haveman J, Reinhold H . The relevance of tumour pH to the treatment of malignant disease. Radiother Oncol. 1984; 2(4):343-66. DOI: 10.1016/s0167-8140(84)80077-8. View

Shen J, Zhao L, Han G . Lanthanide-doped upconverting luminescent nanoparticle platforms for optical imaging-guided drug delivery and therapy. Adv Drug Deliv Rev. 2012; 65(5):744-55. DOI: 10.1016/j.addr.2012.05.007. View

Grange C, Geninatti-Crich S, Esposito G, Alberti D, Tei L, Bussolati B . Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin-containing liposomes in experimentally induced Kaposi's sarcoma. Cancer Res. 2010; 70(6):2180-90. DOI: 10.1158/0008-5472.CAN-09-2821. View

Lee D, Koo H, Sun I, Ryu J, Kim K, Kwon I . Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem Soc Rev. 2011; 41(7):2656-72. DOI: 10.1039/c2cs15261d. View

Peer D, Karp J, Hong S, Farokhzad O, Margalit R, Langer R . Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2008; 2(12):751-60. DOI: 10.1038/nnano.2007.387. View

10.

Hainfeld J, Slatkin D, Smilowitz H . The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol. 2004; 49(18):N309-15. DOI: 10.1088/0031-9155/49/18/n03. View

11.

Lee S, Choi K, Chung H, Ryu J, Lee A, Koo H . Real time, high resolution video imaging of apoptosis in single cells with a polymeric nanoprobe. Bioconjug Chem. 2011; 22(2):125-31. DOI: 10.1021/bc1004119. View

12.

Dolmans D, Fukumura D, Jain R . Photodynamic therapy for cancer. Nat Rev Cancer. 2003; 3(5):380-7. DOI: 10.1038/nrc1071. View

13.

Ma M, Xu H, Chen H, Jia X, Zhang K, Wang Q . A drug-perfluorocarbon nanoemulsion with an ultrathin silica coating for the synergistic effect of chemotherapy and ablation by high-intensity focused ultrasound. Adv Mater. 2014; 26(43):7378-85. DOI: 10.1002/adma.201402969. View

14.

Albanese A, Tang P, Chan W . The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng. 2012; 14:1-16. DOI: 10.1146/annurev-bioeng-071811-150124. View

15.

Yang H, Li Y, Li T, Xu M, Chen Y, Wu C . Multifunctional core/shell nanoparticles cross-linked polyetherimide-folic acid as efficient Notch-1 siRNA carrier for targeted killing of breast cancer. Sci Rep. 2014; 4:7072. PMC: 4233336. DOI: 10.1038/srep07072. View

16.

Weissleder R . A clearer vision for in vivo imaging. Nat Biotechnol. 2001; 19(4):316-7. DOI: 10.1038/86684. View

17.

Shukla S, Steinmetz N . Virus-based nanomaterials as positron emission tomography and magnetic resonance contrast agents: from technology development to translational medicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015; 7(5):708-21. PMC: 4620044. DOI: 10.1002/wnan.1335. View

18.

Min K, Min H, Lee H, Park D, Yhee J, Kim K . pH-controlled gas-generating mineralized nanoparticles: a theranostic agent for ultrasound imaging and therapy of cancers. ACS Nano. 2015; 9(1):134-45. PMC: 5242341. DOI: 10.1021/nn506210a. View

19.

Stride E, Saffari N . Microbubble ultrasound contrast agents: a review. Proc Inst Mech Eng H. 2004; 217(6):429-47. DOI: 10.1243/09544110360729072. View

20.

Yigit M, Moore A, Medarova Z . Magnetic nanoparticles for cancer diagnosis and therapy. Pharm Res. 2012; 29(5):1180-8. PMC: 3734862. DOI: 10.1007/s11095-012-0679-7. View